LION compared with IOVA: revenue, margins and what each company keeps, and the suppliers and customers both name

LIONLionsgate Studios Corp.

Mkt capRevenueRevenue

IOVAIovance Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

LIONLionsgate Studios Corp.

IOVAIovance Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LION

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 7 '26±9.7%▲+0.31%×0.03

May 22 '26±13.0%▲+15.80%×1.22

Feb 6 '26±12.1%▲+2.49%×0.21

Nov 7 '25±13.0%▼−2.28%×0.18

IOVA

3 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±17.9%▲+43.09%×2.41

May 7 '26±16.0%▼−13.20%×0.82

= impliedLION realized, solidIOVA realized, hatchedOne scale, both sides: full bar = 44%× = |realized| ÷ impliedSource: market data

Feb 24 '26

±19.1%

▲+30.80%

×1.61

Nov 6 '25±27.6%▲+27.62%×1.00

LIONLionsgate Studios Corp.

12.35▲+1.74%

Mkt cap$3.5BRevenue$777MQ1 FY27Revenue—

IOVAIovance Biotherapeutics, Inc.

8.67▲+8.10%

Regular sessionNov 3 '26

Mkt cap$3.6BRevenue$99MQ2 FY26Revenue$264MFY25

Compare

Regular sessionNov 3 '26

LIONLionsgate Studios Corp.

IOVAIovance Biotherapeutics, Inc.

12.35▲+1.74%

Price

8.67▲+8.10%

$3.5B

Mkt cap

$3.6B

Q1 FY27$777M

Revenue

$99MQ2 FY26

—

Revenue

$264MFY25

LION12.35▲+1.74%vsIOVA8.67▲+8.10%Regular sessionNov 3 '26